SBC Medical Group Holdings Incorporated (SBC) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

SBC Medical Group Holdings Incorporated (SBC) Industrial Operations Profile

SBC Medical Group Holdings Incorporated offers comprehensive management services to cosmetic treatment centers, operating in Japan, Vietnam, and the United States. The company's integrated support system, encompassing marketing, staff management, and clinic development, positions it as a key enabler for cosmetic treatment franchises.

What Is the Investment Thesis for SBC?

SBC Medical Group Holdings Incorporated presents a compelling investment case due to its established presence in the growing cosmetic treatment market across Japan, Vietnam, and the United States. The company's high profit margin of 29.4% and gross margin of 72.9% demonstrate efficient operations and strong pricing power. With a P/E ratio of 8.0, SBC appears undervalued compared to industry peers, potentially offering significant upside. Growth catalysts include expansion into new geographic markets and the introduction of innovative service offerings. However, investors should be aware of potential risks such as regulatory changes in the cosmetic treatment industry and increased competition.

Based on FMP financials and quantitative analysis

SBC Key Highlights

Market capitalization of $391M indicates a mid-sized player in the consulting services sector.

• P/E ratio of 8.0 suggests potential undervaluation compared to industry averages.
• Profit margin of 29.4% highlights strong profitability and operational efficiency.
• Gross margin of 72.9% demonstrates effective cost management and pricing strategies.
• Beta of 0.99 indicates market correlation, suggesting moderate volatility relative to the overall market.

Who Are SBC's Competitors?

SBC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SBC's Key Strengths?

Established presence in Japan, Vietnam, and the United States.

• Comprehensive suite of management services.
• High profit margin of 29.4%.
• Strong gross margin of 72.9%.

What Are SBC's Weaknesses?

Limited brand recognition compared to larger consulting firms.

• Dependence on the cosmetic treatment industry.
• Potential vulnerability to regulatory changes.
• Geographic concentration in specific markets.

What Could Drive SBC Stock Higher?

SBC catalyst: Expansion into new geographic markets, such as Southeast Asia and Latin America, expected by Q4 2026.

• Development and introduction of innovative service offerings, including advanced marketing analytics and telemedicine solutions.
• Strategic partnerships with leading medical equipment suppliers to provide franchisees with access to cutting-edge technologies.

What Are the Key Risks for SBC?

Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.

• Insider selling — insiders were net sellers of roughly $20.2M recently.
• Increased competition from larger consulting firms and specialized service providers.
• Economic downturns affecting consumer spending on cosmetic treatments.
• Changes in consumer preferences and trends in the cosmetic treatment industry.
• Regulatory changes in the cosmetic treatment industry, which could impact operations and profitability.

What Are the Growth Opportunities for SBC?

• Expansion into New Geographic Markets: SBC can leverage its established business model to expand into additional countries with growing demand for cosmetic treatments, such as Southeast Asia and Latin America. This expansion could increase revenue by 15-20% over the next three years, tapping into a market projected to reach $150 billion by 2029.
• Introduction of Innovative Service Offerings: SBC can develop and offer new, value-added services to its franchisee network, such as advanced marketing analytics, telemedicine solutions, and specialized training programs. These offerings can increase revenue per franchisee by 10-15% annually, enhancing SBC's competitive advantage.
• Strategic Partnerships with Medical Equipment Suppliers: Forming strategic alliances with leading medical equipment suppliers can provide SBC's franchisees with access to cutting-edge technologies and preferential pricing. This can improve the quality of services offered by franchisees and reduce their operating costs, further strengthening SBC's value proposition.
• Development of Proprietary IT Solutions: Investing in the development of proprietary IT solutions tailored for the cosmetic treatment industry can streamline operations, improve customer engagement, and enhance data analytics capabilities. This can lead to increased efficiency and better decision-making, driving revenue growth and profitability.
• Enhancement of Brand Recognition and Marketing Efforts: Strengthening brand recognition through targeted marketing campaigns and digital media strategies can attract new franchisees and customers. This can increase the number of franchisee clinics by 10-15% annually, expanding SBC's market reach and revenue base.

What Are SBC's Competitive Advantages?

• Established network of franchisee cosmetic treatment centers.
• Comprehensive suite of management services.
• International presence in key markets.
• Proprietary IT software solutions tailored for the cosmetic treatment industry.

What Does SBC Do?

Founded in 2000 and headquartered in Irvine, California, SBC Medical Group Holdings Incorporated provides a suite of management services to cosmetic treatment centers. The company operates in Japan, Vietnam, and the United States, offering extensive support to its franchisees. SBC's services include advertising and marketing strategies, staff recruitment and training programs, and a centralized booking system for franchisee clinic customers. Additionally, SBC assists with franchisee employee housing and facility rentals, streamlining operational logistics. The company also oversees the construction and design of franchisee clinics, ensuring brand consistency and operational efficiency. SBC further supports its franchisees through the procurement of medical equipment and consumables, and the provision of IT software solutions tailored for the cosmetic treatment industry. SBC's support extends to a wide array of cosmetic treatments, including breast augmentation, liposuction, rejuvenation treatments, laser skin toning, and hair transplants, enabling its franchisees to offer comprehensive services.

What Products and Services Does SBC Offer?

• Provides advertising and marketing services to cosmetic treatment centers.
• Offers staff management services, including recruitment and training.
• Manages booking reservations for franchisee clinic customers.
• Assists with franchisee employee housing rentals and facility rentals.
• Oversees construction and design of franchisee clinics.
• Procures medical equipment and medical consumables.
• Provides IT software solutions tailored for the cosmetic treatment industry.

How Does SBC Make Money?

• Generates revenue through management service fees charged to franchisee cosmetic treatment centers.
• Offers a comprehensive suite of services, creating a recurring revenue stream.
• Expands its network of franchisees to increase its revenue base.

What Industry Does SBC Operate In?

SBC Medical Group Holdings Incorporated operates within the global cosmetic surgery and services market, which is experiencing steady growth driven by increasing disposable incomes and a rising emphasis on personal aesthetics. The consulting services sector, which SBC is part of, supports this market by providing essential management and operational expertise to cosmetic treatment centers. The competitive landscape includes both large consulting firms and specialized service providers. SBC differentiates itself through its focus on the cosmetic treatment industry and its international presence.

Who Are SBC's Key Customers?

• Franchisee cosmetic treatment centers in Japan, Vietnam, and the United States.
• Independent cosmetic treatment centers seeking management support.
• Medical professionals looking to establish their own cosmetic treatment practices.

Company Profile

SBC Medical Group Holdings Incorporated operates in the Consulting Services industry within the Industrials sector. It is headquartered in Irvine, US. The company is led by CEO Yoshiyuki Aikawa. SBC has traded publicly since 2022.

SBC Medical Group Holdings Incorporated Financial Trajectory

SBC Medical Group Holdings Incorporated (SBC) reported $49.2M in revenue for Q2 2026, reflecting 14.2% growth compared to the prior quarter. The company recorded net income of $10.7M, with diluted EPS of $0.10. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this small-cap Industrials company. Across the four most recent quarters, SBC averaged $0.12 in diluted EPS.

How SBC Medical Group Holdings Incorporated Is Valued

SBC Medical Group Holdings Incorporated carries a market capitalization of $391M, placing it in the small-cap category. Relative to its peer group, SBC's quantitative score of 92/100 is above the peer average of 57/100.

Return on equity for SBC Medical Group Holdings Incorporated stands at 16.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 10.5%, showing how much profit it generates from its asset base. SBC trades at a trailing price-to-earnings ratio of 7.97, below the Industrials sector average of ~32x. Its free cash flow yield is 13.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.82 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 12.5%, the inverse of the P/E and a quick read on earnings relative to price.

SBC Medical Group Holdings Incorporated's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.26 places it in the safe zone, indicating low near-term bankruptcy risk.

SBC Medical Group Holdings Incorporated has missed Wall Street's EPS estimate in 5 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 18.2% below estimates on average.

Wall Street analysts project SBC Medical Group Holdings Incorporated revenue of about $181.0M for fiscal 2026, with EPS near $0.46. The estimate reflects 3 contributing analysts.

Over the past six months, SBC Medical Group Holdings Incorporated insiders filed 5 SEC Form 4 transactions — 4 sales and 1 purchases. On net that is roughly 8.0M shares disposed (about $20.2M), a signal worth weighing alongside the fundamentals.

SBC Financials

SBC Latest News

SBC Analyst Consensus

SBC MoonshotScore

Common Questions About SBC (Industrials)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources